keyword
https://read.qxmd.com/read/38691822/development-and-standardization-of-an-osteoradionecrosis-classification-system-in-head-and-neck-cancer-implementation-of-a-risk-based-model
#1
JOURNAL ARTICLE
Erin E Watson E, Katrina Hueniken, Junhyung Lee, Shao Hui Huang, Amr El Maghrabi, Wei Xu, Amy C Moreno, C Jillian Tsai, Ezra Hahn, Andrew J McPartlin, Christopher M K L Yao, David P Goldstein, John R De Almeida, John N Waldon, Clifton D Fuller, Andrew J Hope, Salvatore L Ruggiero, Michael Glogauer, Ali A Hosni
PURPOSE: Osteoradionecrosis of the jaw (ORN) can manifest in varying severity. The aim of this study is to identify ORN risk factors and develop a novel classification to depict the severity of ORN. METHODS: Consecutive patients with head and neck cancer (HNC) treated with curative-intent intensity-modulated radiation therapy (IMRT) (≥45 Gy) from 2011 to 2017 were included. Occurrence of ORN was identified from in-house prospective dental and clinical databases and charts...
May 1, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38691134/feasibility-of-laparoscopic-robot-assisted-surgery-for-borrmann-type-4-gastric-cancer-a-comparison-study-with-conventional-open-surgery
#2
JOURNAL ARTICLE
Eigo Akimoto, Takahiro Kinoshita, Masahiro Yura, Mitsumasa Yoshida, Takafumi Okayama, Takumi Habu, Masaru Komatsu, Hiromi Nagata, Daiki Terajima
BACKGROUND: Laparoscopic surgery for early gastric cancer is regarded as a standard of care because of robust evidences obtained by several phase-III trials. Furthermore, the efficacy of laparoscopic radical surgery for advanced gastric cancer has been also reported. Meanwhile, the feasibility of laparoscopic surgery for Bormann type 4 gastric cancer, special type with unfavorable prognosis, remains unclear since excluded from eligibility of these trials. METHODS: This study included 100 patients with type 4 gastric cancer who underwent laparoscopic/robot-assisted (minimally invasive surgery (MIS) group; n = 32) or open (Open group; n = 68) curative surgery between 2008 and 2021...
April 30, 2024: Surgical Endoscopy
https://read.qxmd.com/read/38690159/totally-implantable-venous-ports-in-infants-and-children-a-single-center-retrospective-study-of-indications-and-safety
#3
JOURNAL ARTICLE
Patrycja Sosnowska-Sienkiewicz, Sebastian Moryciński, Danuta Januszkiewicz-Lewandowska, Karolina Michalik, Klaudyna Madziar, Agata Kukfisz, Daria Zielińska, Przemysław Mańkowski
INTRODUCTION: Totally Implantable Venous Access Devices (TIVADs) contribute significantly to the treatment progress and comfort of patients requiring long-term therapy. However, the procedure for implanting TIVADs, as well as its very presence, may be associated with complications. AIM: This study evaluates the indications, safety, and complication rates of venous port implantations in pediatric patients. It also explores factors influencing the occurrence of early and late complications post-implantation...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38689824/association-between-pathological-characteristics-and-recurrence-score-by-oncotypedx-in-resected-t1-3-and-n0-1-breast-cancer-a-real-life-experience-of-a-north-hungarian-regional-center
#4
JOURNAL ARTICLE
Dániel Deme, Bálint Ferenc Tamaskovics, Nizar Jammoul, Sándor Kovács, Emmanuel Oladunjoye Kayode, James W Grice, András Telekes
Introduction: The 21-gene analysis (OncotypeDX) is validated test for pT1-3, pN0-1 with hormone receptor (HR) positive and normal expression of human epidermal growth factor receptor-2 (HER2) breast cancer (BC) to determine the aggressiveness of the disease based on the calculation of Recurrence Score (RS). Methods: In this retrospective study the authors correlated pathological characteristics and Recurrence Score (RS) by traditional statistical methods and Observed Oriented Modeling (OOM) in a realistic cohort of BC patients...
2024: Pathology Oncology Research: POR
https://read.qxmd.com/read/38689675/single-center-experiences-a-comparison-of-intracorporeal-and-extracorporeal-anastomosis-outcomes-in-right-hemicolectomy
#5
JOURNAL ARTICLE
Audrey Kim, Munyaradzi G Nyandoro, Linda Vu, Ruben Rajan, Abraham Jacob
Background Anastomosis formed in minimally invasive laparoscopic right hemicolectomy (LRH) may be achieved intra-corporeally (ICA) or extra-corporeally (ECA). This study compared the return of bowel function and other associated early patient outcomes and morbidity rates after an ICA or ECA in LRH. Methodology The study conducted a single-center retrospective cohort study of elective LRH from January 2021 to September 2023. Patient demographics, surgical techniques, and outcomes were analyzed using IBM SPSS Statistics for Windows, Version 29...
April 2024: Curēus
https://read.qxmd.com/read/38689540/late-cognitive-and-adaptive-outcomes-of-patients-with-neuroblastoma-associated-opsoclonus-myoclonus-ataxia-syndrome-a-report-from-the-children-s-oncology-group
#6
JOURNAL ARTICLE
Prerna Kumar, Victoria W Willard, Leanne Embry, Arlene Naranjo, Brian LaBarre, Katherine K Matthay, Pedro A de Alarcon
BACKGROUND: Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare autoimmune disorder of the nervous system presenting with abnormal eye and limb movements, altered gait, and increased irritability. Two to four percent of children diagnosed with neuroblastoma have neuroblastoma-associated OMAS (NA-OMAS). These children typically present with non-high-risk neuroblastoma that is cured with surgery, with or without chemotherapy. Despite excellent overall survival, patients with NA-OMAS can have significant persistent neurological and developmental issues...
April 30, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38689115/leveraging-radiomics-and-machine-learning-to-differentiate-radiation-necrosis-from-recurrence-in-patients-with-brain-metastases
#7
JOURNAL ARTICLE
Mustafa M Basree, Chengnan Li, Hyemin Um, Anthony H Bui, Manlu Liu, Azam Ahmed, Pallavi Tiwari, Alan B McMillan, Andrew M Baschnagel
OBJECTIVE: Radiation necrosis (RN) can be difficult to radiographically discern from tumor progression after stereotactic radiosurgery (SRS). The objective of this study was to investigate the utility of radiomics and machine learning (ML) to differentiate RN from recurrence in patients with brain metastases treated with SRS. METHODS: Patients with brain metastases treated with SRS who developed either RN or tumor reccurence were retrospectively identified. Image preprocessing and radiomic feature extraction were performed using ANTsPy and PyRadiomics, yielding 105 features from MRI T1-weighted post-contrast (T1c), T2, and fluid-attenuated inversion recovery (FLAIR) images...
April 30, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38688798/racial-differences-in-cutaneous-events-among-patients-receiving-enfortumab-vedotin
#8
JOURNAL ARTICLE
Evangelia Vlachou, Ronac Mamtani, Noah M Hahn, Burles Johnson Iii, Jean Hoffman-Censits, Vivek Nimgaonkar
INTRODUCTION: Enfortumab vedotin (EV) is an antibody-drug conjugate approved alone and in combination with pembrolizumab for advanced urothelial cancer (UC). EV-related-cutaneous-events (EVCEs) are common and rarely life-threatening. Black patients are frequently under-represented in oncology trials, and dermatologic conditions may vary with race. METHODS: Therefore, this retrospective analysis investigated differences in EVCE frequency between Black and White patients in an urban cohort (Johns Hopkins [JH]) and a US-based, nationwide electronic health record (EHR)-derived deidentified database (Flatiron Health [FH]) with sub-group analysis of those who had received prior pembrolizumab...
April 7, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38688402/bridging-the-knowledge-practice-gap-insights-from-a-survey-of-belgian-dental-professionals-on-diagnosis-and-supportive-oral-cancer-treatment-in-comparison-with-international-guidelines
#9
JOURNAL ARTICLE
Lien Klaps, Maarten Verbist, Michel Bila, Jeroen Van Dessel
OBJECTIVE: Early detection significantly improves the prognosis of oral cancer patients, contingent upon the knowledge of dental professionals. This study aimed to assess and compare the knowledge, practices and perceptions regarding oral cancer among dental professionals in Belgium. MATERIALS AND METHODS: A cross-sectional survey was distributed via Qualtrics to general dentists, dental specialists, dental hygienists, and oral and maxillofacial surgeons. The self-administered questionnaire comprised three sections: demographics (4 questions), knowledge (9 questions) and clinical practices (19 questions) related to oral cancer detection and treatment...
April 28, 2024: Journal of Stomatology, Oral and Maxillofacial Surgery
https://read.qxmd.com/read/38688192/guidelines-for-the-diagnosis-and-treatment-of-cutaneous-squamous-cell-carcinoma-a-grade-approach-for-evidence-evaluation-and-recommendations-by-the-italian-association-of-medical-oncology
#10
REVIEW
P Queirolo, M Cinquini, G Argenziano, F Bassetto, P Bossi, A Boutros, C Clemente, V de Giorgi, M Del Vecchio, R Patuzzo, E Pennachioli, K Peris, P Quaglino, A Reali, I Zalaudek, F Spagnolo
Cutaneous squamous cell carcinoma (CSCC) accounts for ∼20%-25% of all skin tumors. Its precise incidence is often challenging to determine due to limited statistics and its incorporation with mucosal forms. While most cases have a favorable prognosis, challenges arise in patients presenting with locally advanced or metastatic forms, mainly appearing in immunocompromised patients, solid organ transplantation recipients, or those facing social difficulties. Traditionally, chemotherapy and targeted therapy were the mainstays for advanced cases, but recent approvals of immunotherapeutic agents like cemiplimab and pembrolizumab have revolutionized treatment options...
April 29, 2024: ESMO Open
https://read.qxmd.com/read/38688188/effect-of-surgical-volume-on-short-term-outcomes-of-cytoreductive-surgery-for-advanced-stage-ovarian-cancer-a-population-based-study-from-the-dutch-gynecological-oncology-audit
#11
JOURNAL ARTICLE
M D Algera, W J van Driel, B F M Slangen, M W J M Wouters, R F P M Kruitwagen
OBJECTIVE: Despite lacking clinical data, the Dutch government is considering increasing the minimum annual surgical volume per center from twenty to fifty cytoreductive surgeries (CRS) for advanced-stage ovarian cancer (OC). This study aims to evaluate whether this increase is warranted. METHODS: This population-based study included all CRS for FIGO-stage IIB-IVB OC registered in eighteen Dutch hospitals between 2019 and 2022. Short-term outcomes included result of CRS, length of stay, severe complications, 30-day mortality, time to adjuvant chemotherapy, and textbook outcome...
April 29, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38687407/relationship-between-her2-low-status-and-efficacy-of-cdk4-6-inhibitors-in-advanced-breast-cancer-a-real-world-study
#12
JOURNAL ARTICLE
T Önder, Ö Ateş, I Öner, C Karaçin
AIMS AND OBJECTIVES: Human epidermal growth factor receptor 2 (HER2)-low breast cancer (BC) is a new entity considered a biologically distinct subtype from HER2-zero BC. However, the importance of HER2 low expression on the activity of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) remains unclear. METHODS/MATERIALS: We conducted a single-center retrospective study including hormone receptor-positive (HR +) /HER2- metastatic BC (mBC) patients treated with CDK4/6i plus endocrine treatment (ET) as first-line therapy...
April 30, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38686622/-special-issue-pro-a-demonstration-of-estimands-and-sensitivity-analyses-for-time-to-deterioration-of-patient-reported-outcomes
#13
JOURNAL ARTICLE
Lysbeth Floden, Michael DeRosa, Jessica Roydhouse, Jennifer L Beaumont, Stacie Hudgens
In oncology trials, health-related quality of life (HRQoL), specifically patient-reported symptom burden and functional status, can support the interpretation of survival endpoints, such as progression-free survival. However, applying time-to-event endpoints to patient-reported outcomes (PRO) data is challenging. For example, in time-to-deterioration analyses clinical events such as disease progression are common in many settings and are often handled through censoring the patient at the time of occurrence; however, disease progression and HRQoL are often related leading to informative censoring...
April 30, 2024: Journal of Biopharmaceutical Statistics
https://read.qxmd.com/read/38686569/impact-of-hyperuricemia-and-chronic-kidney-disease-on-the-prevalence-and-mortality-of-cardiovascular-disease-in-cancer-survivors
#14
JOURNAL ARTICLE
Yanlin Chen, Yuhan Chen, Weidong Lin, Lu Fu, Huiyi Liu, Sijia Pu, Haowei Chen, Hong Yi, Yumei Xue
BACKGROUND: The risks of cardiovascular disease (CVD) and CVD mortality are prevalent among cancer survivors (CS) population. The 2022 ESC Guidelines on cardio-oncology have recommended that modifying cardiovascular risk factors (CVRF) could potentially improve long-term outcomes in CS. OBJECTIVES: To identify the independent and joint chronic kidney disease (CKD) associations of hyperuricemia with the incidence of CVD and mortality outcomes among CS. METHODS: Utilizing data from the US National Health and Nutrition Examination Survey spanning 2005-2018, we assessed the risk of CVD through weighted multivariable logistic regression and restricted cubic spline (RCS) regression...
May 2024: Cancer Medicine
https://read.qxmd.com/read/38686266/multicenter-study-on-breast-cancer-in-the-geriatric-population-insights-for-effective-treatment-strategies
#15
JOURNAL ARTICLE
Sule Karabulut Gul, Huseyin Tepetam, Berrin Benli Yavuz, Ozge Kandemir Gursel, Ayşe Altinok, Pelin Altinok, Ahmet Fatih Oruc, Duygu Akincioglu, Raghad Al Shomali, Omar Alomari, Mehmet Alper Kaya
OBJECTIVE: Breast cancer is common among women aged 65 and over. There is a significant lack of evidence regarding the treatment of breast cancer in patients in this age group due to the rare inclusion of these patients in clinical studies. However, it is known that survival in elderly patients with breast cancer is significantly reduced in those not receiving standard therapy. Several factors, including patients' comorbidities, performance status, life expectancy, and tumor pathological and molecular characteristics, can affect the outcomes of treatment...
March 2024: Curēus
https://read.qxmd.com/read/38686232/factors-influencing-anxiety-levels-in-oncology-patients-a-study-on-the-impact-of-earthquakes
#16
JOURNAL ARTICLE
Sule Karabulut Gul, Ahmet Fatih Oruc, Duygu Gedik, Muhammed Edib Mokresh, Omar Alomari, Mehmet Alper Kaya, Duygu Akincioglu, Huseyin Tepetam, Hakan Levent Gul
OBJECTIVE: This study aims to explore the multifaceted factors influencing anxiety levels in oncology patients, with a specific focus on the impact of earthquakes in the context of Turkey. Our objective is to identify and understand sociodemographic, clinical, and lifestyle determinants associated with anxiety in cancer patients, examining how traumatic events, such as earthquakes, contribute to heightened anxiety levels. MATERIALS AND METHODS: A cross-sectional study was conducted, involving 149 oncology patients undergoing treatment at two prominent oncology centers in Turkey...
March 2024: Curēus
https://read.qxmd.com/read/38686197/evaluating-first-line-therapeutic-strategies-for-metastatic-castration-resistant-prostate-cancer-a-comprehensive-network-meta-analysis-and-systematic-review
#17
Duojie Zhang, Haimin Weng, Zhangji Zhu, Weilun Gong, Yinfeng Ma
OBJECTIVE: This study aimed to evaluate the relative efficacy and safety of first-line treatment options for metastatic castration-resistant prostate cancer (mCRPC). METHODS: We systematically searched electronic databases, including PubMed and Web of Science, for studies published from their inception to April 3rd, 2023. Inclusion criteria were: 1) Completed Phase III or IV randomized controlled trials (RCTs) registered on ClinicalTrials.gov; 2) Patients with a confirmed diagnosis of mCRPC who had not previously received chemotherapy or novel endocrine therapies...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38686188/diagnostic-performance-of-the-gallbladder-reporting-and-data-system-combined-with-color-doppler-flow-imaging-for-gallbladder-cancer-in-the-asian-population
#18
JOURNAL ARTICLE
Rongling Wang, Lin Lv, Li Li
PURPOSE: Evaluating the performance of the Gallbladder Reporting and Data System (GB-RADS) combined with Color Doppler Flow Imaging (CDFI) for the diagnosis of gallbladder wall thickening disease in an Asian population. METHODS: In this study, the lesions were classified and the actual incidence rate of malignant tumors was calculated for each GB-RADS category, following the guidelines provided by GB-RADS. To evaluate the diagnostic performance of GB-RADS and GB-RADS combined with CDFI, we plotted Receiver Operator Characteristic (ROC) curves...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38686187/effect-of-different-anaesthetic-techniques-on-the-prognosis-of-patients-with-colorectal-cancer-after-resection-a-systematic-review-and-meta-analysis
#19
Shijun Xia, Yuwen Zhu, Wenjiang Wu, Yue Li, Linchong Yu
BACKGROUND: The effect of total intravenous anaesthesia (TIVA) and inhalation anaesthesia (IA) on the prognosis of patients with colorectal cancer after resection is controversial. This study aimed to explore the effects of different anaesthesia methods on the postoperative prognosis of colorectal cancer. METHODS: PubMed, Embase and Cochrane Library databases were searched for relevant literature from each database's inception until 18 November 2023. The literature topic was to compare the effects of TIVA and IA on the prognosis of patients undergoing colorectal cancer resection...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38685459/thromboembolic-risk-in-prostate-cancer-patients-treated-with-parp-inhibitors-a-systematic-review-and-meta-analysis
#20
REVIEW
Sati Coskun Yazgan, Erman Akkus, Emre Yekeduz, Yuksel Urun
BACKGROUND: Poly (ADP-ribose) polymerase inhibitors (PARPi) have been associated with thrombotic events, although the association with thrombosis risk in different cancers remains poorly defined. METHODS: This meta-analysis included phase II and phase III clinical trials in which patients with metastatic prostate cancer were treated with PARPi either as monotherapy or in combination. The primary endpoints were the rates of thromboembolic events in prostate cancer patients...
April 27, 2024: Critical Reviews in Oncology/hematology
keyword
keyword
100354
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.